AN

Active Director Director DIN 09168642
DIN 09168642 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Amar Nath

Data last updated:

Amar Nath is a Director at Nutriclox Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Nutriclox Pharmaceuticals Private Limited reported revenue of ₹7.4 Lakh (FY 2025).

DIN 09168642
Primary Designation Director
Industry Chemicals
First Appointment 07 May 2021
Oldest Company Age 5 yrs
Largest company Nutriclox Pharmaceuticals Private Limited · ₹7.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20212021₹7.4 Lakh (FY 2025)Active

Board colleagues of Amar Nath

NameDINCompanyDesignation
Ashutosh Kumar09168653Nutriclox Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nutriclox Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amar Nath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amar Nath

Amar Nath currently holds 1 directorship: Nutriclox Pharmaceuticals Private Limited (Director, since 07 May 2021, revenue ₹7.4 Lakh (FY 2025)).

Amar Nath was first appointed on 07 May 2021 as Director at Nutriclox Pharmaceuticals Private Limited.

The current boards of Amar Nath's companies include Ashutosh Kumar (Nutriclox Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available